Investigation of Tumefactive Demyelination is Associated with Higher Economic Burden and More Adverse Events Compared with Conventional Multiple Sclerosis

ConclusionThe cost and morbidity related to investigating TD is higher than in typical MS. Improvements in the diagnosis of TD have the potential to improve health and economic outcomes.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research